Efficacy of diet on fatigue, quality of life and disability status in multiple sclerosis patients: rapid review and meta-analysis of randomized controlled trials.

Autor: Guerrero Aznar MD; Pharmacy Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain. sevilla.lolaguerreroaznar@yahoo.es., Villanueva Guerrero MD; Pharmacy Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain., Cordero Ramos J; Pharmacy Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain., Eichau Madueño S; Neurology Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain., Morales Bravo M; Neurology Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain., López Ruiz R; Neurology Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain., Beltrán García M; Pharmacy Clinical Management Unit, Virgen Macarena University Hospital, Seville, Spain.
Jazyk: angličtina
Zdroj: BMC neurology [BMC Neurol] 2022 Oct 20; Vol. 22 (1), pp. 388. Date of Electronic Publication: 2022 Oct 20.
DOI: 10.1186/s12883-022-02913-w
Abstrakt: Background: Multiple sclerosis is an inflammatory and neurodegenerative disease. People with multiple sclerosis (pwMS) experience chronic fatigue which is difficult to deal with therapeutically and greatly affects health-related quality of life (QOL). PwMS are aware of the lack of generalized dietary advice related to their disease, leading to self-experimentation with diet. It is necessary to provide objective information about dietary interventions for pwMS. We aim to provide an objective synthesis of the evidence for efficacy and safety of specific diets in pwMS through a rapid review and meta-analyses of randomized controlled trials (RCTs), examining symptomatic fatigue (MFIS), QOL, Expanded-Disability-Status-Scale (EDSS), and severe adverse events.
Methods: We have carried out a rapid review (MEDLINE and EMBASE) up to December 2021, with PRISMA methodology, and meta-analyses, of (RCTs). All statistical analyses were performed using the comprehensive meta-analysis (CMA) -RStudio 4.1.3. The analysis used weighted mean differences (WMD) and a 95% confidence interval (CI) using a random-effects model to compare the effects of the dietary intervention with the control.
Results: Eight studies met the inclusion criteria. Of these eight studies, five analyzed EDSS, three MFIS, and three QOL. A total of 515 patients were analyzed. These meta-analyses cumulative evidence support that dietary intervention is associated with a trend of reduction in fatigue (308 patients studied) -the difference between means (SMD) of the control group and intervention group was -2,033, 95%-IC (-3,195, -0,152), a p-value of 0.0341)-, an increase in QOL (77 patients studied), no significant effect on EDSS (337 patients studied), and no severe adverse events.
Conclusions: It is difficult to reach a high level of evidence in dietary studies. Our findings show that dietary intervention is associated with a trend of reduction in fatigue in MS. Taking into account the potential of dietary interventions and the benefit/risk ratio in their favor, neurologists must be aware of the great importance of making interventions on diet in MS if necessary. There are dietary interventions with some evidence of benefit for patients with MS, which could be chosen based on adherence, patient preferences, and individual outcomes. Large prospective clinical trials are needed to shed further light on this topic.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje